Hepatitis Diagnostic Test Market Size, Share & Trends by 2034

Coverage: By By Diagnostic Tests (Blood Tests, Imaging Tests, Liver Biopsy); End Users (Hospital, Clinics Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00016868
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Hepatitis Diagnostic Test Market Size, Share & Trends by 2034
Report Date: April 17, 2026   |   Report Code: TIPRE00016868 Email: sales@theinsightpartners.com

2025 Market Size

US$ 4.26 Bn

Base year value

2034 Forecast

US$ 7.75 Bn

Projected by 2034

CAGR 2026-2034

6.88 %

Growth rate

Addressable Market

US$ 54.27 Bn

(2026-2034)

The global hepatitis diagnostic test market size is projected to reach US$ 7.75 billion by 2034 from US$ 4.26 billion in 2025. The market is anticipated to register a CAGR of 6.88% during the forecast period 2026-2034.

The report is categorized by Diagnostic Tests (Blood Tests, Imaging Tests, Liver Biopsy) and further analyzes the market based on End Users (Hospital, Clinics Others). A comprehensive breakdown is provided at global, regional, and country levels for each of these key segments.

The report includes market size and forecasts across all segments, presenting values in USD. It also delivers key statistics on the current market status of leading players, along with insights into prevailing market trends and emerging opportunities.

Purpose of the Report

The report Hepatitis Diagnostic Test Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Hepatitis Diagnostic Test Market Segmentation Diagnostic Tests

  1. Blood Tests
  2. Imaging Tests
  3. Liver Biopsy

End Users

  1. Hospital
  2. Clinics Others

Market Assessment and Insights

  • Global market for Hepatitis Diagnostic Test was valued at US$ 4.26 Billion in 2025
  • Annual market size is expected to reach US$ 7.75 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 54.27 Billion
  • Market is anticipated to register a CAGR of 6.88% during the forecast period
  • The United States represents a key market, supported by Innovative Testing Solutions Transform Hepatitis Diagnosis, Rising Awareness Fuels Demand for Hepatitis Screening, Government Initiatives Boost Access to Diagnostic Services, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Revolutionizing Hepatitis Testing: Fast, Accurate, and Affordable Solutions, Empowering Patients: At-Home Hepatitis Testing Kits for Easy Access, Innovative Tech: AI-Driven Diagnostics Transforming Hepatitis Detection are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Siemens Ag, F. Hoffmann La-Roche, Abbott Laboratories, DiaSorin S.p.A, MedMira, Inc, bioMeriuex, Hologic, Inc, Danaher Corporation, Bio-Rad Laboratories, QIAGEN, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • ● Segmentations
  • ● Geography
  • ● Competitive Analysis
  • ● Language Preferences

Hepatitis Diagnostic Test Market: Strategic Insights

hepatitis-diagnostic-test-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Hepatitis Diagnostic Test Market Growth Drivers

  1. Innovative Testing Solutions Transform Hepatitis Diagnosis
  2. Rising Awareness Fuels Demand for Hepatitis Screening
  3. Government Initiatives Boost Access to Diagnostic Services

Hepatitis Diagnostic Test Market Future Trends

  1. Hepatitis Diagnostics Embrace AI for Faster, Accurate Results
  2. Home Testing Kits Revolutionize Hepatitis Screening Accessibility
  3. Personalized Medicine: Tailoring Hepatitis Treatments to Individual Needs

Hepatitis Diagnostic Test Market Opportunities

  1. Revolutionizing Hepatitis Testing: Fast, Accurate, and Affordable Solutions
  2. Empowering Patients: At-Home Hepatitis Testing Kits for Easy Access
  3. Innovative Tech: AI-Driven Diagnostics Transforming Hepatitis Detection

Hepatitis Diagnostic Test Market Report Scope

Report Attribute Details
Market size in 2025 US$ 4.26 Billion
Market Size by 2034 US$ 7.75 Billion
Global CAGR (2026 - 2034) 6.88%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Diagnostic Tests
  • Blood Tests
  • Imaging Tests
  • Liver Biopsy
By End Users
  • Hospital
  • Clinics Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Siemens Ag
  • F. Hoffmann La-Roche
  • Abbott Laboratories
  • DiaSorin S.p.A
  • MedMira, Inc
  • bioMeriuex
  • Hologic, Inc
  • Danaher Corporation
  • Bio-Rad Laboratories
  • QIAGEN

Hepatitis Diagnostic Test Market Players Density: Understanding Its Impact on Business Dynamics

The Hepatitis Diagnostic Test Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

hepatitis-diagnostic-test-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Hepatitis Diagnostic Test Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Hepatitis Diagnostic Test Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA